Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean A Fletcher

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Prostate Cancer and Prostatic Diseases|June 26, 2019
Contemporary national trends in prostate cancer risk profile at diagnosisSean A Fletcher, Nicolas von Landenberg, Alexander P Cole, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Total Gleason Pattern 4 Length Outperforms Grade Group and Clinical Models in Predicting Oncologic Outcomes in Grade Group 2-4 Prostate CancerNicholas A Pickersgill, Sean A Fletcher, Nate Aiken, et al.
BJU International|June 12, 2025
Clinically significant prostate cancer detected by systematic biopsy in patients with MRI lesionsSean A Fletcher, Mark N Alshak, Seoho Lee, et al.
Cancer|February 26, 2016
Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national databaseSean A Fletcher, Angel M Cronin, Amer M Zeidan, et al.
Clinical Genitourinary Cancer|March 7, 2019
Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive TherapyPhilipp Gild, David-Dan Nguyen, Sean A Fletcher, et al.
Prostate Cancer and Prostatic Diseases|April 14, 2019
Prostate cancer in the medicare shared savings program: are Accountable Care Organizations associated with reduced expenditures for men with prostate cancer?Alexander P Cole, Anna Krasnova, Ashwin Ramaswamy, et al.
Cancer|October 19, 2019
The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 yearsSean A Fletcher, Alexander P Cole, Chang Lu, et al.
Urologic Oncology|January 23, 2025
Metformin intake and risk of metabolic acidosis after radical cystectomy with urinary diversion: A comparative study using data from the TriNetX research networkMaximilian Pallauf, Stephan Brönimann, Michael E Rezaee, et al.
The Journal of Urology|December 18, 2023
Risk of Biochemical Recurrence in Patients With Grade Group 1 Prostate Cancer With Extraprostatic Extension Treated With Radical ProstatectomyMichael E Rezaee, Maximilian Pallauf, Sean A Fletcher, et al.
AUA News|August 19, 2024
JU INSIGHT Biochemical Recurrence in Patients With Grade Group 1 Prostate Cancer With Extraprostatic ExtensionMichael E Rezaee, Maximilian Pallauf, Sean A Fletcher, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Prostate Cancer and Prostatic Diseases|June 26, 2019
Contemporary national trends in prostate cancer risk profile at diagnosisSean A Fletcher, Nicolas von Landenberg, Alexander P Cole, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Total Gleason Pattern 4 Length Outperforms Grade Group and Clinical Models in Predicting Oncologic Outcomes in Grade Group 2-4 Prostate CancerNicholas A Pickersgill, Sean A Fletcher, Nate Aiken, et al.
BJU International|June 12, 2025
Clinically significant prostate cancer detected by systematic biopsy in patients with MRI lesionsSean A Fletcher, Mark N Alshak, Seoho Lee, et al.
Cancer|February 26, 2016
Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national databaseSean A Fletcher, Angel M Cronin, Amer M Zeidan, et al.
Clinical Genitourinary Cancer|March 7, 2019
Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive TherapyPhilipp Gild, David-Dan Nguyen, Sean A Fletcher, et al.
Prostate Cancer and Prostatic Diseases|April 14, 2019
Prostate cancer in the medicare shared savings program: are Accountable Care Organizations associated with reduced expenditures for men with prostate cancer?Alexander P Cole, Anna Krasnova, Ashwin Ramaswamy, et al.
Cancer|October 19, 2019
The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 yearsSean A Fletcher, Alexander P Cole, Chang Lu, et al.
Urologic Oncology|January 23, 2025
Metformin intake and risk of metabolic acidosis after radical cystectomy with urinary diversion: A comparative study using data from the TriNetX research networkMaximilian Pallauf, Stephan Brönimann, Michael E Rezaee, et al.
The Journal of Urology|December 18, 2023
Risk of Biochemical Recurrence in Patients With Grade Group 1 Prostate Cancer With Extraprostatic Extension Treated With Radical ProstatectomyMichael E Rezaee, Maximilian Pallauf, Sean A Fletcher, et al.
AUA News|August 19, 2024
JU INSIGHT Biochemical Recurrence in Patients With Grade Group 1 Prostate Cancer With Extraprostatic ExtensionMichael E Rezaee, Maximilian Pallauf, Sean A Fletcher, et al.
Pageof 6